# Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention

> **NCT01738100** · PHASE2 · UNKNOWN · sponsor: **Hyeon-Cheol Gwon** · enrollment: 100 (estimated)

## Conditions studied

- ST-Segment Elevation Myocardial Infarction

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel
- **DRUG:** Morphine Sulfate
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01738100
- **Lead sponsor:** Hyeon-Cheol Gwon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01738100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01738100, "Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01738100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*